ERES East Resources Acquisition Company

Three Diverse Drug Developers Award $5 Million in Later Phase Programs to eResearchTechnology Agreements Highlight eRT's Competitive Strength to Provide the Most Comprehensive Analysis Methods and Provide Multinational Logistics Support and Address Massive Amounts of Data Across Four Continents PHILADELPHIA, April 4 /PRNewswire-FirstCall/ -- eResearchTechnology, Inc. (eRT), (NASDAQ:ERES), a leading provider of centralized electrocardiographic (ECG) collection and interpretation services, announced today that it has been awarded more than $5 million in cardiac safety monitoring and services for three significant later phase development programs by three diverse sponsors. The sponsors include a top 20 global pharma launching an important Phase III program utilizing semi-automated readings, a significant Phase III program extension that leverages fully manual measurement methodology by a fast growing mid-tier organization, and eRT's initial award from an emerging European biopharmaceutical for semi-automated readings for a critical Phase III program. The three programs include research sites distributed across four continents. eRT is providing comprehensive support, including provision of more than 400 units of digital 12-lead ECG equipment designed to facilitate collection of cardiac safety data that is subsequently provided to eRT for analysis. eRT will perform digital collection, measurement, interpretation, review, and distribution of cardiac safety data through its EXPeRT workflow enabled data handling technology, the first solution in production that was designed explicitly to meet emerging international regulatory guidance and technical standards. "We are delighted to have been selected by these three diverse drug developers for these important programs, which highlight eRT's unique competitive strength to address large programs that require substantial capabilities in the ECG collection equipment marshalling and logistics areas, along with substantial multilingual site support services for the duration of these extensive, complex initiatives," said Scott Grisanti, senior vice president of business development and chief marketing officer at eRT. "These awards are significant because they illustrate eRT's continued collaboration with two important long-time clients and the addition of a new client, who has made eRT its partner of choice for critical cardiac safety services." Based in Philadelphia, PA, eResearchTechnology, Inc. (http://www.ert.com/) is a provider of technology and services to the pharmaceutical, biotechnology and medical device industries on a global basis. The company is a market leader in providing centralized core-diagnostic electrocardiographic (ECG) technology and services to evaluate cardiac safety in clinical development. The company is also a leader in providing technology and services to streamline the clinical trials process by enabling its customers to automate the collection, analysis, and distribution of clinical data in all phases of clinical development. Statements included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as competitive factors, technological development, market demand, and the company's ability to obtain new contracts and accurately estimate net revenues due to variability in size, scope and duration of projects, and internal issues in the sponsoring client. The sponsors may cancel these agreements at their sole discretion. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the company's financial results can be found in the company's Reports on Form 10-K filed with the Securities and Exchange Commission. DATASOURCE: eResearchTechnology, Inc. CONTACT: Joan Sterlacci of eResearchTechnology, Inc., +1-908-203-6473, or Matt Hayden of Hayden Communications, +1-858-704-5065, for eResearchTechnology Web site: http://www.ert.com/

Copyright